-

BioFlyte Appoints Former U.S. Ambassador and National Security Advisor John Bolton to Board of Directors

Ambassador Bolton brings decades of experience in national security, foreign policy, and diplomacy to BioFlyte as the company looks to expand its critical infrastructure business

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--BioFlyte, a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced that former U.S. Ambassador and National Security Advisor John Bolton has joined its Board of Directors. As a board member, Ambassador Bolton will help drive awareness for the company and its bio-threat detection technology within the global security market.

Ambassador Bolton most recently served as the National Security Advisor from 2018 to 2019. In 2005, he was nominated to the post of United States Ambassador to the United Nations by President George W. Bush and held that position until the end of 2006. He served as a United States Assistant Attorney General for President Ronald Reagan from 1985 to 1989. Ambassador Bolton then served in the State Department as Assistant Secretary of State for International Organization Affairs from 1989 to 1993, and Under Secretary of State for Arms Control and International Security Affairs from 2001 to 2005. Ambassador Bolton is also the author of the best-selling books “Surrender Is Not an Option: Defending America at the United Nations and Abroad” and “The Room Where It Happened”. He regularly appears as a guest on television and radio and writes columns for major media publications.

“We are honored to welcome Ambassador Bolton to the BioFlyte Board of Directors,” said Charles Call, Ph.D., cofounder, and CEO of BioFlyte. “He has broad and internationally-recognized expertise in preventing the proliferation of weapons of mass destruction, security threats and vulnerabilities related to critical infrastructure that will help bring our cutting-edge bio-threat detection technology to the global security market.”

“We were very pleased to attract Ambassador Bolton to the Board of Directors of BioFlyte,” said Wayne Bryden, PhD, CEO of Zeteo Tech and member of the BioFlyte Board of Directors. “The global relationships he built while serving as United States Ambassador to the United Nations and as the United States National Security Advisor, among many other critical roles, will help advance international awareness of BioFlyte’s critical technologies.”

“BioFlyte has developed a new generation of biothreat detection and mitigation technologies that can play a major role in critical infrastructure protection on an international level,” said Ambassador John Bolton. “I look forward to working with the team and the rest of the Board of Directors to raise awareness of the benefits this new technology has for the global security landscape.”

To learn more about BioFlyte and its technology, please visit https://bioflyte.com.

About BioFlyte

BioFlyte is a biodefense and microbial identification company that is commercializing a revolutionary new class of fieldable biological contamination sampling, detection, and identification solutions. The firm’s current application focus is critical infrastructure protection and pandemic response. For more information about BioFlyte and its products, please visit: https://bioflyte.com.

Contacts

Media
Kalyn Schieffer for BioFlyte – kos@anzupartners.com

BioFlyte


Release Summary
Former U.S. Ambassador and National Security Advisor John Bolton has joined the BioFlyte Board of Directors to help drive awareness for the company
Release Versions

Contacts

Media
Kalyn Schieffer for BioFlyte – kos@anzupartners.com

More News From BioFlyte

BioFlyte Partners with Los Alamos National Laboratory to Optimize Modeling and Simulation Tools for Biothreat Detection and Response

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--BioFlyte has a new collaboration with Los Alamos National Laboratory as part of the New Mexico Technology Readiness Gross Receipts (TRGR) initiative....

BioFlyte Awarded U.S. Air Force SBIR Phase II Contract to Advance BioTOF System for Ground-Based Chem/Bio Aerosol Detection

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--BioFlyte has been awarded a Small Business Innovation Research (SBIR) Phase II contract by the U.S. Air Force with a focus on ruggedizing the BioTOF....

BioFlyte Awarded U.S. Department of Homeland Security SAFETY Act Designation for Qualified Anti-Terrorism Technology

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--U.S. DHS has awarded BioFlyte a SAFETY Act Designation for its aerosol chem/biothreat detection and identification technology....
Back to Newsroom